A bill to amend the Securities Exchange Act of 1934 to require additional disclosure for pharmaceutical companies.

United States115th CongressS-2885Senate
Latest legislative activity: May 17, 2018

Summary

Official Summary

Disclosing Pharmaceutical Company Windfall Profits Act of 2018

This bill amends the Securities Exchange Act of 1934 to require pharmaceutical companies to make certain public disclosures, including disclosures related to taxation, compensation, dividends, and spending on research and development.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

    Senate

All available records shown.